Catalyst
Slingshot members are tracking this event:
FDA Denies PTC Therapeutics' (PTCT) Appeal of Refuse to File Letter Regarding Translarna in Treatment of Nonsense Mutation Duchenne Muscular Dystrophy
Do you think this event is important to the companies below? How will it affect their stock price?
| Related Companies | Importance
|
Impact on Stocks
|
||||
|---|---|---|---|---|---|---|
| PTCT |
|
|
||||
Slingshot Insights Explained
Catalyst Date
Occurred on:
Oct 17, 2016
Related Projects
-
Don’t see a project related to the catalyst you care about?
Related Keywords
Refuse To File Letter, Appeal, Denial, Translarna, Nonsense Mutation, Duchenne Muscular Dystrophy
